News

Huisman had issues a press announcement that it had concluded an agreement with BMW for the design and construction of a so-called “ringer crane”, a special kind of heavy-lifting land cranes. Following Huisman’s press statement, Mammoet issued a press release entitled “Mammoet starts investigation of patent infringement by Huisman and BMS”, in which it refers

The District Court of The Hague (Provisions Judge) has rejected Novartis’ application, based on a patent application, for a preliminary injunction (PI), meaning Mylan can market its generic drug containing fingolimod in the Netherlands at least prior to the grant of the patent. The EPO’s Technical Board of Appeal had recently cleared the way for

In its interim decision of 22 March 2022 the PI judge of the District Court of The Hague ruled in the PI proceedings in Novartis v Mylan that the market entry by Mylan with its generic fingolimod 0.5mg product prior to Novartis’ patent entering into force, is not unlawful. Given the very short time between

Recently, two interesting judgments were published in separate SEP/FRAND proceedings. The first decision pertains to a confidentiality regime and the second to an ex parte AASI. Confidentiality regime In the SEP/FRAND proceedings between Philips et al. vs. Xiaomi et al the District Court of The Hague (“DC”) decided on 14 July 2021 (decision published in

In an earlier Pharma Update, we reported on the judgment of the District Court of The Hague of 14 October 2020 in which AstraZeneca AB (“AstraZeneca”) was ordered to pay damages to health insurer Menzis Zorgverzekeraar NV (“Menzis”) for having enforced a patent that was later invalidated against a generic company.   This judgment has now

On 16 December 2021 the PI Judge of the District Court of The Hague (“PI Judge”) rendered a judgment in PI proceedings initiated by Telefonaktiebolaget LM Ericsson (“Ericsson”) against Apple Retail Netherlands B.V., Apple Benelux B.V., Apple Inc., Apple Distribution International and Apple Sales International Ltd (“Apple et al.”). Ericsson is the patent proprietor of

The BarentsKrans’ IP & Technology team contributed to The Legal 500: Patent Litigation Country Comparative Guide  by providing the chapter on patent litigation in The Netherlands. By means of a Q&A this guide describes the most important aspects of patent litigation in 27 countries worldwide. Each chapter provides information about the current issues affecting patent

The IAM Patent 1000 ‘The World’s Leading Patent Professionals 2021’ identifies the best patent specialists around the world. BarentsKrans has again secured a silver position this year as one of the world’s leading patent law firms. IAM Patent 1000 on BarentsKrans: Since its inception, BarentsKrans has provided game-changing support in complex disputes for global pioneers

On 30 December 2020 (published 13 January 2021), the District Court of The Hague (“the Court”) rendered a judgment in final relief proceedings initiated by Adaptive Spectrum and Signal Alignment, Incorporated (“ASSIA”) against Koninklijke KPN N.V., Telfort Zakelijk B.V., XS4ALL Internet B.V., KPN B.V. (collectively “KPN”) and Nokia Solutions and Networks Nederland B.V. (“Nokia”) regarding